1. Deteriorating wait times for breast cancer patients at a regional hospital in BC, 2013 versus 2023: Treating breast cancer is an interdisciplinary endeavor, but delays among the various independently functioning components of the care continuum have contributed to increasing wait times
- Author
-
Hwang, Hamish, Parker, R. Quinn, Horkoff, Michael, Humphreys, Michael, Hardy, Edward, McClellan, Kira, Brierley, Yann, Brosseau, Laurent, and Rempel, Hannah
- Subjects
- *
FISHER exact test , *SURGERY , *CANCER patient care , *MEDICAL referrals , *CONTINUUM of care , *MEDICAL care wait times , *TREATMENT delay (Medicine) - Abstract
Background: Breast cancer is a common condition, and the number of cases is projected to increase 52% between 2012 and 2030. Care of breast cancer patients occurs along an interdisciplinary continuum involving family physicians, general surgeons, radiologists, pathologists, medical oncologists, radiation oncologists, and allied health workers. There are national benchmarks for wait times between each step from diagnosis to treatment. In this quality improvement project, we sought to measure these wait times at our hospital by comparing results for 2013 and 2023, identifying causes of delays, and proposing solutions to reduce wait times. Methods: We included all patients who were diagnosed with breast malignancies and referred to the general surgery service at Vernon Jubilee Hospital in 2013 and 2023. Results were analyzed using the two-tailed t test and Fisher exact test for continuous and categorical variables, respectively. A P value less than .05 was considered significant. Results: The number of patients increased from 69 in 2013 to 113 in 2023. Mean wait times from initial imaging referral to surgery increased from 67 to 114 days (P < .01) during this period. Mean wait times from imaging referral to pathology diagnosis increased from 36 to 71 days (P < .01), due primarily to an increase from 34 to 80 days for symptomatic patients who were referred by their family physician (P < .01); wait times for asymptomatic patients who were identified by the Screening Mammography Program increased from 40 to 58 days (P = .09). Mean wait times from biopsy to final biomarker report (ER/PR/HER2) increased from 25 days to 29 days (P = .25), from surgery to final pathology increased from 11 to 17 days (P < .01), from surgical consultation to surgery increased from 17 to 31 days (P < .01), from referral to medical oncology consultation increased from 14 to 30 days (P < .01), and from referral to radiation oncology consultation increased from 78 to 106 days (P = .025). Most wait times met benchmark wait times in 2013 but failed to meet them in 2023. Conclusions: Wait times increased at every stage of the care continuum for breast cancer patients between 2013 and 2023 at Vernon Jubilee Hospital. Implementing an interdisciplinary approach to care is necessary to remediate sources of delays at each step. Possible solutions include creating a fast-track pathway for symptomatic patients, performing biomarkers and pathology slide preparation locally, increasing operating room time, and tripling the number of oncologists in the region. [ABSTRACT FROM AUTHOR]
- Published
- 2024